GLP Watchdog

Gala vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. Gala has none. On brand-name semaglutide pen, Gala costs $1,212 less a year at standing rates: $1,299 a month against $1,400 a month at SkinnyRx.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / SkinnyRx

Gala logo

Gala

8.5/10

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$248/moBrand-name semaglutide pill
States
All 50 states
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Gala
Visit SkinnyRx

Both Gala and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Gala has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On brand-name semaglutide pen, Gala costs $1,212 less a year at standing rates: $1,299 a month against $1,400 a month at SkinnyRx.

  4. 04

    Only SkinnyRx lists a price for brand-name tirzepatide pen, compounded oral semaglutide and compounded oral tirzepatide.

  5. 05

    Gala covers three states SkinnyRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

SkinnyRx

Compounded semaglutide injection

$179/mo

$2,148 a year

$99/mo

first month only; not compared

Compounded tirzepatide injection

$179/mo

$2,148 a year

$99/mo

first month only; not compared

Brand-name semaglutide pen

$1,299/moLower

$15,588 a year

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Gala: October 17, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
  • No FDA warning letter on record
  • $1,212 a year less on brand-name semaglutide pen
  • Names no compounding pharmacy
Visit Gala

The case for SkinnyRx

6.3/10
  • Sells brand-name tirzepatide pen and compounded oral semaglutide, which Gala does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Gala 8.5 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
2.0

Accessibility10%

10.0A
vs
B
9.5

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Gala has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Gala, by $1,212 a year at standing rates. Gala: $1,299 a month, about $15,588 a year. SkinnyRx: $1,400 a month, about $16,800 a year.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
Both Gala and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks